Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 9, 2007, Pages 1319-1325

  Uchio, Eiichi ^a   Fuchigami, Aki ^a   Kadonosono, Kazuaki ^b   Hayashi, Akio ^c   Ishiko, Hiroaki ^c   Aoki, Koki ^d   Ohno, Shigeaki ^d  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

^d HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenovirus; Anti HIV agent; Epidemic keratoconjunctivitis; Nucleoside reverse transcriptase inhibitor; Stavudine; Zalcitabine

Indexed keywords

AMPRENAVIR; INDINAVIR; NEVIRAPINE; STAVUDINE; VIRUS DNA; ZALCITABINE;

ADENOVIRUS; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA EXTRACTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KERATOCONJUNCTIVITIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; VIRUS REPLICATION; VIRUS STRAIN;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ANTI-HIV AGENTS; CELL LINE; CONJUNCTIVITIS, VIRAL; DNA, VIRAL; EPITHELIAL CELLS; GENE DOSAGE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS CULTIVATION;

EID: 34548032134     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0523-z     Document Type: Article

References (41)

1. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A (2001) Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 32:1290-1297
2. Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M (2003) Adenovirus infection in hematopoietic stem cell transplantation: Effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant 9:341-352
3. Cotton M, Weber JM (1995) The adenovirus protease is required for virus into host cells. Virology 213:494-502
4. D'Cruz OJ, Uckun FM (2005) Stampidine: A selective oculo-genital microbicide. J Antimicrob Chemother 56:10-19
5. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, Slaterus KW, Wertheim-Van Dillen P, Van Doornum GJ, Khoo SH, Hierholzer JC (1999) Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37:3940-3945
6. De Oliveira B, Stevenson D, LaBree L, McDonnel PJ, Trousdale MD (1996) Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res 31:165-172
7. Ford E, Nelson KE, Warren E (1987) Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 9:244-261
8. Gavin PJ, Katz BZ (2002) Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics 110:1-8
9. Gordon YG, Romanowski EG, Araullo-Cruz TP, Seaberg L, Erzurum S, Tolman R, De Clercq E (1991) Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic-GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res 16:11-16
10. Gordon YG, Romanowski EG, Araullo-Cruz TP (1994) Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci 35:4135-4143
11. Green M, Pina M (1964) Biochemical studies an adenovirus multiplication, VI. Properties of highly purified tumorigenic human adenoviruses and their DNA's. Proc Natl Acad Sci USA 51:1251-1259
12. Hoffman JA, Shah AJ, Ross LA, Kapoor N (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7:388-394
13. Jernigan JA, Lowry BS, Hayden FG, Kyger SA, Conway BP, Groschel DH, Farr BM (1993) Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: Risk factors and control. J Infect Dis 167:1307-1313
14. Kapelushnik J, Or R, Delukina M, Nagler A, Livni N, Engelhard D (1995) Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation. J Pediatr Gastroenterol Nutr 21:110-112
15. Kakuda TN (2000) Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22:685-708
16. Kaneko H, Kato K, Mori S, Shigeta S (2001) Antiviral activity of NMSO3 against adenovirus in vitro. Antivir Res 52:281-288
17. Kimura T, Mori S, Tomita K, Ohno K, Takahashi K, Shigeta S, Terada M (2000) Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo. Antiviral Res 47:41-51
18. Kinchington PR, Turse SE, Kowalski RP, Gordon YJ (1994) Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Invest Ophthalmol Vis Sci 35:4126-4134
19. Lankester AC, Heemskerk B, Claas EC, Schilham MW, Beersma MF, Bredius RG, van Tol MJ, Kroes AC (2004) Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis 38:1521-1525
20. Legrand F, Berrebi D, Houhou N, Freymuth F, Faye A, Duval M, Mougenot JF, Peuchmaur M, Vilmer E (2001) Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplant 27:621-626
21. Maslo C, Girard P, Urban T, Guessant S, Rozenbaum W (1997) Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Crit Care Med 156:1263-1264
22. Mentel R, Kinder M, Wegner U, Janta-Lipinski M, Matthes E (1997) Inhibitory activity of 3′-fluoro-2′-deoxythymidine and related nucleoside analogues against adenovirus in vitro. Antiviral Res 34:113-119
23. Mentel R, Wegner U (2000) Evaluation of the efficacy of 2′,3′-dideoxycydine against adenovirus infection in a mouse pneumonia model. Antiviral Res 47:79-87
24. Mentel R, Kurek S, Wegner U, Janta-Lipinski M, Gurtler L, Matthes E (2000) Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level. Med Microbiol Immunol (Berl) 189:91-95
25. Mitsuya H, Jarrett RF, Matsukura M, Di Marzo Veronese F, DeVico AL, Sarngadharan MG, Johns DG, Reitz MS, Broder S (1987) Long-term inhibition of human T-lymphotropic virus type III/ lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2′,3′-dideoxynuculoosides in vitro. Proc Natl Acad Sci USA 84:2033-2037
26. Monkemuller KE, Wilcox CM (2000) Esophageal ulcer caused by cytomegalovirus: Resolution during combination antiretroviral therapy for acquired immunodeficiency syndrome. South Med J 93: 818-820
27. Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, Kroes AC, van Tol MJ, Thouvenot D (2005) In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther 10:225-229
28. Murphy GF, Wood DP, McRoberts JW, Henslee-Downey PJ (1993) Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol 149:565-566
29. Naesens L, Lenaerts L, Andrei G, Snoeck R, Van Beers D, Hol A, Balzarini J, De Clercq E (2005) Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother 49:1010-1016
30. O'Donnell B, McCruden EA, Desselberger U (1993) Molecular epidemiology of adenovirus conjunctivitis in Glasgow 1981-1991. Eye 7:8-14
31. Romanowski EG, Gordon YJ (2000) Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Invest Ophthalmol Vis Sci 41:460-463
32. Simpson DM, Tagliati M (1995) Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9:153-161
33. Sircar S, Ruzindana-Umunyana A, Neugebauer W, Weber JM (1998) Adenovirus endopeptidase and papain are inhibited by the same agents. Antivir Res 40:45-51
34. Tanaka-Yokogui K, Itoh N, Usui N, Takeuchi S, Uchio E, Aoki K, Usui M, Ohno S (2001) New genome type of adenovirus serotype 19 causing nosocomial infections of epidemic keratoconjunctivitis in Japan. J Med Virol 65:530-533
35. Trousdale MD, Goldschmidt PL, Nobrega R (1994) Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea 13:435-439
36. van der Vliet PC, Kwant MM (1981) Role of DNA polymerase gamma in adenovirus DNA replication. Mechanism of inhibition by 2′,3′-dideoxynucleoside 5′-triphosphates. Biochemistry 20:2628-2632
37. Wadell G, de Jong JC (1980) Restriction endonucleases in identification of a genome type of adenovirus 19 associated with keratoconjunctivitis. Infect Immun 27:292-296
38. Wadell G, Hammarskjold ML, Winberg G, Varsanyi TM, Sundell G (1980) Genetic variability of adenoviruses. Ann N Y Acad Sci 354:16-42
39. Wadell G (1984) Molecular epidemiology of human adenoviruses. Curr Top Microbiol Immunol 110:191-220
40. Walls T, Shankar AG, Shingadia D (2003) Adenovirus: An increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis 3:79-86
41. Zarraga AL, Kerns FT, Kitchen LW (1992) Adenovirus pneumonia with severe sequelae in an immunocompetent adult. Clin Infect Dis 15:712-713